Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Stomach Neoplasms 1 Lung Neoplasms 1 Diarrhea 1 Colonic Polyps 1 Colonic Neoplasms 1 Colitis, Ulcerative 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Barrett Esophagus 1 Adenocarcinoma of Lung 1

Interventions

Carboplatin 7 Pemetrexed 5 pembrolizumab 4 Gemcitabine 4 osimertinib 3 Sorafenib 3 Paclitaxel 3 Interleukin-2 3 Cyclophosphamide 3 Cisplatin 3 seocalcitol 2 selinexor 2 patritumab 2 liposomal doxorubicin 2 interferon gamma-1b 2 fludarabine 2 Sunitinib 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Irinotecan 2 Erlotinib Hydrochloride 2 DNA 2 Celecoxib 2 Capecitabine 2 Bleomycin 2 Bevacizumab 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 volociximab 1 thioredoxin reductase inhibitor AM12 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinoma × Endoscopy × Clear all

NCT01727908 2019-09-16

FamGaCan

Radboud University Medical Center

Phase NA Terminated

Gastrointestinal

Carcinoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡